Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02542540
Other study ID # 1201174
Secondary ID
Status Terminated
Phase N/A
First received September 3, 2015
Last updated January 19, 2016
Start date July 2013
Est. completion date December 2015

Study information

Verified date September 2015
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Children with osteogenesis imperfecta are described as extremely sedentary and therefore fatigable, which strongly impacts their daily activities. The physical rehabilitation of these children is a fundamental aspect of treatment.

It has been shown that playing Wii console causes the same increase in energy expenditure than practicing moderate exercise, while ensuring user safety. This type of physical exercise with this type of fun game console might have a role in the treatment of OI children on the physical side but also on the psychological side.


Recruitment information / eligibility

Status Terminated
Enrollment 20
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 6 Years to 18 Years
Eligibility Inclusion Criteria:

- - Children affiliated to a social security scheme

- Children diagnosed OI by a competent physician of one of the French specialist centers;

- OI children type 1 or type 4;

- Stable OI (far from a fractional episode of at least two months);

- Children without regular activity on the Nintendo Wii console or other interactive console;

- Boy or Girl> 6 to 18 years

- Parents or person having parental authority affiliated to a social security scheme

- Parents or person having parental authority who signed the consent form for the study.

Exclusion Criteria:

- - Children who can not walk;

- Children with severe OI other than type 1 or type 4;

- Fracture during the last two months;

- Surgical intervention within the last 8 months;

- Inability to understand and follow the protocol;

- Participation in another clinical study;

- Children, parents or holder of parental authority refusing the written consent.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Other:
Training with Nintendo Wii console
Children with OI and draining for 3 months using Nintendo Wii console

Locations

Country Name City State
France CHU Saint-Etienne Saint-Etienne

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne Fondation de France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in physical capacity Compare the change in physical capacity between training group of children with OI and control group of children with OI. The physical capacity is measured by maximal oxygen consumption VO2 max (ml/min/kg) measured during incremental exercise on cycle ergometer from baseline to 3 months No
Secondary Change in physical capacity Compare the change in physical capacity between training group of children with OI and control group of children with OI. The physical capacity is measured by maximal oxygen consumption VO2 max (ml/min/kg) measured during incremental exercise on cycle ergometer From baseline to 9 months No
Secondary Compare physical inactivity between training group and control group Physical inactivity will be assessed by the Physical Activity Questionnaire (Q-APS) Month 3 No
Secondary Compare physical inactivity between training group and control group Physical inactivity will be assessed by the Physical Activity Questionnaire (Q-APS) Month 9 No
Secondary Compare functional benefit between training group and control group The functional benefit will be evaluated by the Functional Independence Measure (FIM) Month 3 No
Secondary Compare functional benefit between training group and control group The functional benefit will be evaluated by the Functional Independence Measure (FIM) Month 9 No
Secondary Compare body fat between training group and control group Body fat composition will be determined by skinfold measurements Month 3 No
Secondary Compare body fat between training group and control group Body fat composition will be determined by skinfold measurements Month 9 No
Secondary Compare quality of life between training group and control group The quality of life will be determined the Index Questionnaire Reintegration to Normal Life (IRVN) Month 3 No
Secondary Compare quality of life between training group and control group The quality of life will be determined the Index Questionnaire Reintegration to Normal Life (IRVN) Month 9 No
Secondary Compare muscle strength between training group and control group The muscle strength is a composite outcome. It will be assessed by:
The grip strength (force applied by the hand)
The maximal quadriceps muscle strength will be measured using an isokinetic dynamometer "Contrex"
Month 3 No
Secondary Compare muscle strength between training group and control group The muscle strength is a composite outcome. It will be assessed by:
The grip strength (force applied by the hand)
The maximal quadriceps muscle strength will be measured using an isokinetic dynamometer "Contrex"
Month 9 No
Secondary Compare endurance of lower limbs between training group and control group The endurance of the lower limbs will be measured by EMG analysis on incremental torque repetitive exercise Month 3 No
Secondary Compare endurance of lower limbs between training group and control group The endurance of the lower limbs will be measured by EMG analysis on incremental torque repetitive exercise Month 9 No
Secondary Compare Energy expenditure of lower limbs between training group and control group Energy expenditure is a composite outcome. It will be measured by collecting the respiratory exchange and heart rate during endurance, tennis and boxing games using the Nintendo WII Month 3 No
Secondary Compare Energy expenditure of lower limbs between training group and control group Energy expenditure is a composite outcome. It will be measured by collecting the respiratory exchange and heart rate during endurance, tennis and boxing games using the Nintendo WII Month 9 No
Secondary Training tolerance Reentrainment tolerance is a composite outcome. It will be assessed by :
collecting any events related to WII training or any events related to everyday life (fractures, pain,etc.)
dropout rate study report
Baseline from 9 months No
See also
  Status Clinical Trial Phase
Completed NCT03557567 - NGS Strategy Effectiveness in Molecular Diagnosis
Not yet recruiting NCT05559801 - Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI) Phase 1/Phase 2
Active, not recruiting NCT02531087 - Urinary Biomarkers of OI Pathobiology
Completed NCT01713231 - Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta Phase 4
Completed NCT00655681 - Prevention of Post Operative Bone Loss in Children N/A
Recruiting NCT06065111 - Study of Osteogenesis Imperfecta Tendon
Withdrawn NCT03216486 - An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Phase 2
Recruiting NCT06086613 - A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers Phase 1
Completed NCT04009733 - Epigenetic Regulation of Osteogenesis Imperfecta Severity : miROI Study N/A
Completed NCT04231916 - High Resolution Thermal Imaging to Identify Vertebral Fractures in Children and Young People With Osteogenesis Imperfecta N/A
Active, not recruiting NCT02814591 - Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy
Completed NCT00982124 - An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta Phase 3
Completed NCT00001305 - Growth Hormone Therapy in Osteogenesis Imperfecta Phase 3
Completed NCT04119388 - Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta N/A
Terminated NCT01679080 - The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta Phase 2
Completed NCT00106028 - Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children Phase 3
Recruiting NCT04152551 - Effects of Bisphosphonates on OI-Related Hearing Loss Phase 4
Completed NCT00705120 - Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation Phase 1
Recruiting NCT04169568 - Osteogenesis Imperfecta Blood Pressure Study
Completed NCT03064074 - Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta Phase 1